KMT - Kennametal Inc.
PITTSBURGH, May 19, 2026 /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) (the "Company") today announced that it has commenced an underwritten public offering of senior notes (the "Notes Offering"). The exact amount and terms of the Notes Offering will depend upon market conditions and other factors.
Kennametal to Attend KeyBanc Capital Markets 2026 Industrials and Basic Materials Conference PR Newswire PITTSBURG
PITTSBURGH, May 18, 2026 /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) announced today that they will attend the KeyBanc Capital Markets 2026 Industrials & Basic Materials Conference in Boston. Details of the conference are as follows: When: Wednesday, May 27, 2026 Attendees: Sanjay Chowbey, President and Chief Executive Officer Patrick Watson, Vice President and Chief Financial Officer Michael Pici, Vice President, Investor Relations About Kennametal With over 85 years as an industrial technology leader, Kennametal Inc. delivers productivity to customers through materials science, tooling and wear-resistant solutions.
Kennametal NYSE: KMT raised its fiscal 2026 sales and adjusted earnings outlook after reporting stronger-than-expected third-quarter results, as higher tungsten-related pricing, modest volume improvement and share gains across key markets lifted revenue and margins.
Investors interested in Manufacturing - Tools & Related Products stocks are likely familiar with Kennametal (KMT) and Sandvik AB (SDVKY). But which of these two stocks is more attractive to value investors?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
KMT beats Q3 fiscal 2026 estimates as sales jump 22%, margins expand and Earthworks, Energy and Aerospace demand stay strong.
Pre-Market Stock Futures: Futures are trading modestly higher after a blowout midweek rally spurred by reports that a peace agreement with Iran could be forthcoming soon and by incredible technology earnings and forecasts that destroyed Wall Street estimates. All of the major indices were once again printing new highs as investors cheered the potential for... Here Are Thursday's Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More
Kennametal Inc. (KMT) Q3 2026 Earnings Call Transcript
Kennametal (KMT) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.47 per share a year ago.
Sales of $593 million increased 22 percent and 19 percent on a reported and organic basis, respectively Operating income of $79 million and adjusted operating income of $82 million, up 80 percent and 64 percent, respectively Earnings per diluted share (EPS) of $0.75 and adjusted EPS of $0.77, up 85 percent and 65 percent, respectively Company raises annual sales and adjusted EPS Outlook PITTSBURGH, May 6, 2026 /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) (the "Company") today reported results for its fiscal 2026 third quarter ended March 31, 2026. "Our third quarter results exceeded the high end of our sales and adjusted EPS Outlook, primarily due to the unprecedented rise in tungsten pricing and stronger volume," said Sanjay Chowbey, President and CEO.
HWM heads into Q1 earnings with strong aerospace demand expected to drive growth, though supply-chain issues and transport softness linger.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Kennametal (KMT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top-ranked stocks Kennametal (KMT), Reddit Inc. (RDDT), Valero Energy (VLO) and PIPER SANDLR CP (PIPR) are likely to beat on the bottom line in their upcoming releases.
KMT, TPR, RL and CLS post impressive interest coverage ratios, signaling a stronger ability to meet debt interest from operating earnings.
Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, independent of mutation status, when combined with standard-of-care targeted and non-targeted therapies including revumenib (menin-KMT2A inhibitor), gilteritinib (FLT3 inhibitor), and azacitidine (hypomethylating agent) - three pillars of modern AML treatment - supporting its potential role as a universal combination backbone Transcriptional reprogramming identified as a central mechanism showing that Actimab-A combinations don't just add cytotoxicity, they reprogram AML cells from proliferation toward differentiation and apoptosis, providing the mechanistic basis for deeper, more durable MRD-negative responses and reinforcing Actimab-A's role as a universal combination backbone across AML Robust cytotoxicity observed in primary AML patient samples across key mutations (FLT3, KMT2A, NPM1, IDH1, IDH2, or TP53), reinforcing Actimab-A's potential as a mutation-agnostic backbone therapy, complementing the manageable safety profile of Actimab-A observed across prior clinical trials in over 150 AML patients NEW YORK, April 22, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association for Cancer Research (AACR) Annual Meeting supporting transcriptional reprogramming as a central mechanism driving the mutation-agnostic anti-leukemic activity of Actimab-A (lintuzumab-Ac225) in acute myeloid leukemia (AML). Preclinical translational data demonstrated that lintuzumab-Ac225 delivers potent cytotoxic activity across AML models harboring common mutations, including FLT3, NPM1, KMT2A, and TP53, as well as in primary patient samples.
Kennametal (KMT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is how Kennametal (KMT) and Karat Packing (KRT) have performed compared to their sector so far this year.
Kennametal (KMT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.